Targeted radiation zaps advanced prostate cancer in new trial
NCT ID NCT05413850
Summary
This study is testing a new radioactive drug called lutetium (177Lu) rhPSMA-10.1 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies. The goal is to find a safe and effective dose that can shrink tumors by delivering radiation directly to cancer cells. The study will involve about 82 men whose cancer has progressed after prior treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beatson West of Scotland Cancer Center
RECRUITINGGlasgow, G12 0YN, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Biogenix Molecular LLC
RECRUITINGMiami, Florida, 33165, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Bristol Hematology and Oncology Center
RECRUITINGBristol, BS2 8ED, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Rechts der Isar
RECRUITINGMunich, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
James Cook University Hospital
RECRUITINGMiddlesbrough, TS4 3BW, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jules Bordet Institute
WITHDRAWNBrussels, 1000, Belgium
-
Meander Medisch Centrum
RECRUITINGAmersfoort, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Radboud UMC
RECRUITINGNijmegen, Gelderland, 6525GA, Netherlands
Contact Email: •••••@•••••
-
Saint Luc University Hospital
RECRUITINGBrussels, 1200, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St Bartholomew's Hospital
RECRUITINGLondon, EC1A 7BE, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Center Sart-Tilman
WITHDRAWNLiège, 4000, Belgium
-
University Hospital Essen
RECRUITINGEssen, Germany
Contact Email: •••••@•••••
-
University Hospital Ghent
RECRUITINGGhent, 9000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Leuven
RECRUITINGLeuven, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Southampton NHS Foundation Trust
RECRUITINGSouthampton, SO16 6YD, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Weill Cornell Medicine - New York - Presbyterian Hospital
COMPLETEDNew York, New York, 10065, United States
-
Weston Park
RECRUITINGSheffield, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
XCancer Omaha / Urology Cancer Center
RECRUITINGOmaha, Nebraska, 68130, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.